Evaluation of Risk Management Methods for Satsuma Mandarin

Simulation of production budgets were used to compare net discounted returns and the distribution of returns under alternative risk-mitigation scenarios. Results indicate that the combination of freeze protection and crop insurance increases expected net discounted 20-year returns while decreasing the downside risk. Break-even prices ranged from $.257 to$.289 per pound. Crop insurance returns were constant across price.Satsuma oranges, freeze protection, crop insurance, production budget, simulation, Crop Production/Industries, Farm Management, Risk and Uncertainty, C63, D81, Q12,

Mandarin Market Segments Based on Consumer Sensory Evaluations

Ninety-five consumers in seven grocery stores tasted unidentified peeled sections of three mandarins (a tangerine, a satsuma, and a clementine), and provided demographic and purchase information. Forty-four percent of the respondents preferred tangerines, 34 percent satsumas, and 22 percent clementines. The probability of preferring each of type of mandarin was estimated from internal quality analysis of paired samples, as well as from demographic and purchase responses. Model simulations were used to recommend harvest standards for satsumas based on Brix-to-acid ratios.Demand and Price Analysis, Food Consumption/Nutrition/Food Safety,

Developing Common Metrics for the Clinical and Translational Science Awards (CTSAs): Lessons Learned.

The National Institutes of Health (NIH) Roadmap for Medical Research initiative, funded by the NIH Common Fund and offered through the Clinical and Translational Science Award (CTSA) program, developed more than 60 unique models for achieving the NIH goal of accelerating discoveries toward better public health. The variety of these models enabled participating academic centers to experiment with different approaches to fit their research environment.A central challenge related to the diversity of approaches is the ability to determine the success and contribution of each model. This paper describes the effort by the Evaluation Key Function Committee to develop and test a methodology for identifying a set of common metrics to assess the efficiency of clinical research processes and for pilot testing these processes for collecting and analyzing metrics. The project involved more than one-fourth of all CTSAs and resulted in useful information regarding the challenges in developing common metrics, the complexity and costs of acquiring data for the metrics, and limitations on the utility of the metrics in assessing clinical research performance. The results of this process led to the identification of lessons learned and recommendations for development and use of common metrics to evaluate the CTSA effort